请选择一种语言

单击以下选项之一即表示您同意我们的 Cookie 政策隐私政策.


Please select a language

By clicking on one of options below you are agreeing to our Cookie Policy and Privacy Policy.

EN 中文

Bringing Innovative Speciality and Rare disease products to China

Leveraging rapid growth in the China pharmaceutical market, CSP has built a pipeline of innovative de-risked products addressing the unmet medical needs of Chinese patients

Experienced

Deep understanding and experience of the legal and regulatory environment to facilitate getting products approved in China

Innovative

Strong collaborations with Chinese hospitals, key opinion leaders, industrial partners and government associations

Successful

Proven track record of accessing abbreviated regulatory development pathways and commercialisation success

Why partner with CSP?

  • British company with Chinese subsidiary operating to Western standards of quality and compliance
  • IP licensed to a UK business and protected by UK law
  • Experts in pharmaceutical market in China
  • Interface with Western team to make interactions easier
  • Takes responsibility for and funds all activities related to China development, approval & commercialisation

Local Experts: CSP is headquartered in London and has offices in Beijing and Shanghai

London

Level 30,
The Leadenhall Building,
122 Leadenhall Street,
London, EC3V 4AB

+44 (0)2037 534691

Beijing

Level 24, China Central Place Tower 3
Room 2467, No. 77 Jianguo Road,
Chaoyang District,
Beijing 100025

+86 10 8588 0036

Shanghai

Level 23 Citigroup Tower,
33 Huayuanshiqiao Road,
Pudong District,
Shanghai 200120

+86 10 8588 0036

Accelerating clinical and regulatory approval in China